Safety Pharmacology
Home » Services » Safety Studies » Safety Pharmacology

Safety Pharmacology

photo:Safety Pharmacology

Studies are conducted in full compliance with the Guidelines on Safety Pharmacology Studies for Human Pharmaceuticals (ICH-S7A and S7B). Plasma drug levels can also be analyzed upon request.

INA has several specialty areas, including cardiovascular studies in a complete atrioventricular block cynomolgus monkey model, as well as central nervous system drug dependence studies in rhesus monkeys and rats for drugs acting on the central nervous system.

Core battery studies

  • Central nervous system (mice, rats, canines and cynomolgus monkeys)
    • Functional observational battery (FOB) in rats, canines and non-human primates, or modified Irwin's method in mice (both tests including body temperature measurements) are used to assess effects on the central nervous system.
  • Cardiovascular system (canines and cynomolgus monkeys)
    • ECG, heart rate and blood pressure are measured in unanesthetized animals using a telemetry system. ECG and heart rate measurements are also possible using an ambulatory Holter ECG monitor. Further more, measurements are also possible during the infusion of a test article into catheterized animals. Animals can be restrained or unrestrained.
    • ECG, heart rate, blood pressure, left ventricular pressure and blood flow are measured in anesthetized animals.
    • Assessment of the effects of a test article on hERG currents. (Both HEK293 and CHO cells are available.)
  • Respiratory system (rats, canines and cynomolgus monkeys)
    • Respiratory rate, tidal volume and minute ventilation are measured in unrestrained, conscious rats.
    • Blood gases are measured in conscious canines or non-human primates.

Follow-up and supplemental studies

  • Central nervous system
    • Gross behavioral observations (canines and cynomolgus monkeys)
      Gross behavioral observations include cage-side observations, response to external stimuli, and observations of secretions and excreta. Non-human primates can be most beneficial, depending on the specific properties of a test article, due to their different metabolic pathways to mice and rats.
    • Motor coordination (mice and rats)
    • Motor activity (mice and rats)
    • Synergistic/antagonistic effects on anesthesia (mice and rats)
    • Algesic effects (mice and rats )
      Details available upon request.
    • Observation for catalepsy (mice and rats)
      Catalepsy-inducing effects are evaluated by scoring the duration of time animals spend standing on their hind legs.
    • Observation for catalepsy (canines and rhesus monkeys)
      Catalepsy-inducing effects are evaluated by scoring the respective durations of standing and resting positions.
    • Aversion (rhesus monkeys)
      Aversion effects are assessed in rhesus monkeys that are trained to press a lever to obtain feed. These monkeys are observed for decreasing lever-pressing rates when injection and feeding occur simultaneously.
  • Cardiovascular and respiratory systems (rats, guinea pigs, cynomolgus monkeys)
    • The chronic atrioventricular block (AVB) monkey model allows highly sensitive detection of the onset of drug-induced QT prolongation and deadly proarrhythmia such as Torsades de Pointes (TdP). The necessity to predict TdP with the accuracy that this model allows is discussed in the ICH-S7B Guideline (2005) for the US, EU and Japan.
    • Action potential duration (APD) is determined using the ventricular or papillary muscles of guinea pigs.
    • Cardiac effects are investigated using isolated guinea pig atrium.
    • Airway resistance is assessed by measuring the Enhanced pause (Penh) in unrestrained, unanesthetized rats.
  • Gastrointestinal system
    • Gastrointestinal transit (mice and rats )
      Effects on gastrointestinal transit are investigated using charcoal powder or barium.
    • Gastrointestinal mucosa (rats)
      Effects on the gastrointestinal mucosa are investigated based on gross and histopathological examinations in necropsied rats.
    • Gastric secretions (rats, canines and cynomolgus monkeys)
      Effects on gastric secretions are investigated by pylorus ligation method in rats, or gastric lavage method in rats, canines and cynomolgus monkeys.
    • Intestinal secretions (rats)
      Effects on intestinal secretions are investigated by measuring water content in the intestinal tract of rats, which is ligated and isolated after a certain period of time from dosing.
    • Bile secretions (rats)
      Effects on bile secretions are investigated in conscious rats.
    • Emesis response (canines and cynomolgus monkeys)
      Frequency of treatment-related vomiting and vomitus are observed.
  • Autonomic nervous system (rats, rabbits and guinea pigs)
    • Effects on the autonomic system are evaluated using isolated ileum from rats or guinea pigs, or isolated blood vessels or other extracted organs from rabbits.
  • Skeletal muscle (mice and rats)
    • Effects on the neuromuscular junction are assessed using sciatic nerve-gastrocnemius specimens obtained from rats.
  • Renal/urinary system (rats, canines and cynomolgus monkeys)
    • Effects on water and electrolyte metabolism are assessed by measuring urinary volume and Na, K, and Cl levels.
  • Blood (rats, rabbits and canines)
    • Effects on hemolysis and blood coagulation are assessed.